Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
Institut de Recherche en Cancérologie de Montpellier, INSERM, Université Montpellier, Institut Régional du Cancer, Montpellier, France.
Front Immunol. 2021 May 20;12:685218. doi: 10.3389/fimmu.2021.685218. eCollection 2021.
Despite decades of clinical and preclinical investigations, we still poorly grasp our innate immune response to human adenoviruses (HAdVs) and their vectors. In this study, we explored the impact of lactoferrin on three HAdV types that are being used as vectors for vaccines. Lactoferrin is a secreted globular glycoprotein that influences direct and indirect innate immune response against a range of pathogens following a breach in tissue homeostasis. The mechanism by which lactoferrin complexes increases HAdV uptake and induce maturation of human phagocytes is unknown. We show that lactoferrin redirects HAdV types from species B, C, and D to Toll-like receptor 4 (TLR4) cell surface complexes. TLR4-mediated internalization of the HAdV-lactoferrin complex induced an NLRP3-associated response that consisted of cytokine release and transient disruption of plasma membrane integrity, without causing cell death. These data impact our understanding of HAdV immunogenicity and may provide ways to increase the efficacy of HAdV-based vectors/vaccines.
尽管经过了几十年的临床和临床前研究,我们仍然对人体腺病毒(HAdV)及其载体的固有免疫反应知之甚少。在这项研究中,我们探讨了乳铁蛋白对三种正在被用作疫苗载体的 HAdV 类型的影响。乳铁蛋白是一种分泌的球形糖蛋白,在组织稳态受到破坏后,它可以影响针对一系列病原体的直接和间接固有免疫反应。乳铁蛋白复合物增加 HAdV 摄取并诱导人吞噬细胞成熟的机制尚不清楚。我们发现,乳铁蛋白将 B、C 和 D 型 HAdV 重新导向 Toll 样受体 4(TLR4)细胞表面复合物。TLR4 介导的 HAdV-乳铁蛋白复合物内吞作用诱导了 NLRP3 相关反应,包括细胞因子释放和质膜完整性的短暂破坏,但不会导致细胞死亡。这些数据影响了我们对 HAdV 免疫原性的理解,并可能为提高基于 HAdV 的载体/疫苗的功效提供途径。